News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
820,191 Results
Type
Article (75809)
Company Profile (643)
Press Release (743739)
Multimedia
Podcasts (126)
Webinars (14)
Section
Business (227928)
Career Advice (3776)
Deals (39186)
Drug Delivery (129)
Drug Development (89293)
Employer Resources (198)
FDA (17851)
Job Trends (17119)
News (388075)
Policy (38792)
Tag
Academia (2999)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56144)
ALS (102)
Alzheimer's disease (1503)
Antibody-drug conjugate (ADC) (161)
Approvals (17812)
Artificial intelligence (307)
Autoimmune disease (29)
Automation (16)
Bankruptcy (402)
Best Places to Work (12632)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (440)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (308)
Cancer (2465)
Cardiovascular disease (210)
Career advice (3218)
Career pathing (34)
CAR-T (175)
Cell therapy (493)
Cervical cancer (22)
Clinical research (72161)
Collaboration (928)
Company closure (1)
Compensation (572)
Complete response letters (30)
COVID-19 (2867)
CRISPR (50)
C-suite (274)
Cystic fibrosis (109)
Data (2334)
Decentralized trials (2)
Denatured (43)
Depression (56)
Diabetes (302)
Diagnostics (6920)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (135)
Drug pricing (128)
Drug shortages (33)
Duchenne muscular dystrophy (103)
Earnings (94279)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (129157)
Executive appointments (785)
FDA (19236)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (822)
Gene editing (125)
Generative AI (30)
Gene therapy (363)
GLP-1 (855)
Government (5134)
Grass and pollen (6)
Guidances (108)
Healthcare (20875)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (150)
Indications (30)
Infectious disease (3030)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (58)
Intellectual property (102)
Interviews (742)
IPO (17720)
IRA (51)
Job creations (4973)
Job search strategy (2627)
Kidney cancer (11)
Labor market (44)
Layoffs (558)
Leadership (24)
Legal (9921)
Liver cancer (82)
Lung cancer (347)
Lymphoma (160)
Machine learning (8)
Management (65)
Manufacturing (361)
MASH (78)
Medical device (14622)
Medtech (14627)
Mergers & acquisitions (22026)
Metabolic disorders (801)
Multiple sclerosis (88)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (34)
Neuroscience (2116)
NextGen: Class of 2025 (7636)
Non-profit (5082)
Now hiring (41)
Obesity (431)
Opinion (275)
Ovarian cancer (80)
Pain (104)
Pancreatic cancer (91)
Parkinson's disease (161)
Partnered (22)
Patents (256)
Patient recruitment (119)
Peanut (51)
People (64173)
Pharmaceutical (132)
Pharmacy benefit managers (22)
Phase I (22290)
Phase II (31463)
Phase III (23731)
Pipeline (1329)
Policy (176)
Postmarket research (3280)
Preclinical (9887)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (434)
Real estate (7156)
Recruiting (75)
Regulatory (26089)
Reports (57)
Research institute (2655)
Resumes & cover letters (589)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (143)
Series B (94)
Service/supplier (27)
Sickle cell disease (59)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4194)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (51)
The Weekly (81)
Vaccines (818)
Venture capitalists (44)
Weight loss (306)
Women's health (38)
Worklife (20)
Date
Today (310)
Last 7 days (912)
Last 30 days (3105)
Last 365 days (35311)
2025 (12167)
2024 (37916)
2023 (42567)
2022 (53927)
2021 (58722)
2020 (57665)
2019 (51316)
2018 (39098)
2017 (36856)
2016 (37795)
2015 (43818)
2014 (38554)
2013 (34691)
2012 (36538)
2011 (36588)
2010 (36121)
Location
Africa (1199)
Alabama (60)
Alaska (7)
Arizona (248)
Arkansas (14)
Asia (48542)
Australia (8346)
California (6572)
Canada (2085)
China (571)
Colorado (287)
Connecticut (302)
Delaware (163)
Europe (110466)
Florida (959)
Georgia (222)
Hawaii (1)
Idaho (63)
Illinois (626)
India (30)
Indiana (337)
Iowa (12)
Japan (174)
Kansas (110)
Kentucky (28)
Louisiana (15)
Maine (70)
Maryland (982)
Massachusetts (5045)
Michigan (249)
Minnesota (425)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (67)
New Hampshire (70)
New Jersey (1856)
New Mexico (31)
New York (1855)
North Carolina (1135)
North Dakota (9)
Northern California (2822)
Ohio (223)
Oklahoma (15)
Oregon (46)
Pennsylvania (1447)
Puerto Rico (13)
Rhode Island (36)
South America (1572)
South Carolina (26)
South Dakota (1)
Southern California (2433)
Tennessee (106)
Texas (981)
United States (25142)
Utah (196)
Virginia (174)
Washington D.C. (72)
Washington State (606)
West Virginia (3)
Wisconsin (70)
820,191 Results for "jefferies and co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
May 5, 2025
·
2 min read
Biotech Bay
Medable to Present at Jefferies Global Healthcare Conference
Medable Inc. today announced that Medable Co-founder and CEO Michelle Longmire will present at the Jefferies Global Healthcare Conference.
May 30, 2024
·
1 min read
Press Releases
ALK enters into neffy® co-promotion agreement in the USA
May 5, 2025
·
3 min read
Enterome to Participate in the 2024 Jefferies Global Healthcare Conference
Enterome announces that Pierre Bélichard, Enterome’s co-founder and Chief Executive Officer, and Christelle Dumoussaud, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on June 4-6, 2024.
May 30, 2024
·
2 min read
Biotech Bay
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
Kezar Life Sciences, Inc. (Nasdaq: KZR) today announced that Chris Kirk, Co-founder and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 12:30 pm ET in New York, NY.
May 29, 2024
·
1 min read
Genetown
PureTech to Present at the Jefferies Global Healthcare Conference
PureTech Health plc today announced that Bharatt Chowrira, Ph.D., J.D., Chief Executive Officer, and Eric Elenko, Ph.D., Co-founder and President, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6th, 2024, at 10:00am EDT / 3:00pm BST.
May 23, 2024
·
3 min read
Press Releases
Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 23, 2025
·
4 min read
Biotech Bay
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for the potential treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s Co-Founder and Chief Executive Officer, is scheduled to host investor meetings at the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on June 4-6, 2024.
May 28, 2024
·
1 min read
Biotech Beach
Masimo to Present in Jefferies Global Healthcare Conference
Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 1:00 p.m. Eastern Time.
May 29, 2024
·
3 min read
Press Releases
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine
April 28, 2025
·
3 min read
1 of 82,020
Next